Vesselin® Drug Coated Coronary Balloon Catheter

Vesselin® Drug Coated Coronary Balloon Catheter Details

Product Description  

Indications：

• Recommended for the treatment of stent restenosis, small vessel disease, and branch lesions.

• Clinical evidence supports primary coronary artery lesions such as macrovascular lesions.

Materials

• Improved PEBAX guarantees higher flexibility and enhanced crossability

Drug

• Loaded Paclitaxel inhibits restenosis continuously.

Drug Coating

• Coated with Active Pharmaceutical Ingredients grade urea, provide better biocompatibility, facilitate drug-releasing effectively.

Delivery system

• Spiral cut hypotube design, strengthen the transition section, bring optimized deliverability for transition.

Product Features

Drug Coating

Coating with Active Pharmaceutical Ingredients grade urea, provide better biocompatibility, facilitate drug-releasing electively. Drug release rate in vivo achieves more than 90%.

The suitable particle size at 2-3µm, enables long term efficacy and low embolism risk

Drug

Paclitaxel loaded with drug dose at 3µg/mm², inhibits restenosis continuously

Delivery System

Spiral cut hypotube design, strengthens the transition section, brings optimized deliverability for transition.

Materials

Improved PEBAX material, lower crossing profile guarantees higher flexibility and enhanced crossability.

Technique Parameters

Balloon Material: PEBAX  

Euective length: 1350mm  

Distal Shaft O.D.: 2.7F

Balloon crossing profile: 0.026'' - 0.035''  

Guiding catheter compatibility: 5F and above  

Guide wire compatibility: 0.014''

Balanced safety and effectiveness

Compared with the control group, no significant difference in late lumen loss in

the segment in 9 months, thrombosis and TLF in 12 months.(TLF: Target lesion failure)

Drug balloon manipulation procedures instruction